Tellit (Medical Records Systems) Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $680K

  • Investors
  • 1

Tellit (Medical Records Systems) General Information


Developer of a medical records platform designed to change the way doctors and medical practitioners view patient records. The company's platform improves diagnostic capabilities by using a natural language processor to generate a summary of patient history relevant to the clinical decision at hand, enabling doctors and physicians to use the exact data of patients to improve their diagnosis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Records Systems
Other Industries
Other Healthcare Services
Primary Office
  • 31910 Del Obispo
  • Suite 100
  • San Juan Capistrano, CA 92675
  • United States
+1 (949) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tellit (Medical Records Systems) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 28-Jun-2016 $680K 00.000 Completed Startup
1. Seed Round 14-Jan-2015 00000 00000 Completed Startup
To view Tellit (Medical Records Systems)’s complete valuation and funding history, request access »

Tellit (Medical Records Systems) Patents

Tellit (Medical Records Systems) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170235888-A1 Systems and methods for creating contextualized summaries of patient notes from electronic medical record systems Inactive 12-Feb-2016 0000000000 0

Tellit (Medical Records Systems) Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Frost Data Capital Venture Capital Minority 000 0000 000000 0
To view Tellit (Medical Records Systems)’s complete investors history, request access »